Murine models of idiopathic inflammatory myopathy

AbstractIdiopathic inflammatory myopathies (IIMs) are characterized by inflammation of muscles and other organs. Several myositis-specific autoantibodies (MSAs) have been identified in IIMs and were found to be associated with distinct clinical features. Although MSAs are valuable for the diagnosis...

Full description

Bibliographic Details
Main Authors: Risa Konishi, Yuki Ichimura, Naoko Okiyama
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Immunological Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/25785826.2022.2137968
_version_ 1811168428201869312
author Risa Konishi
Yuki Ichimura
Naoko Okiyama
author_facet Risa Konishi
Yuki Ichimura
Naoko Okiyama
author_sort Risa Konishi
collection DOAJ
description AbstractIdiopathic inflammatory myopathies (IIMs) are characterized by inflammation of muscles and other organs. Several myositis-specific autoantibodies (MSAs) have been identified in IIMs and were found to be associated with distinct clinical features. Although MSAs are valuable for the diagnosis of IIMs, the pathogenic roles of these antibodies remain unknown. To investigate the pathogenesis of IIMs, several animal models of experimental myositis have been established. Classical murine models of autoimmune myositis, experimental autoimmune myositis, and C protein-induced myositis are established by immunization with muscle-specific antigens, myosin, and skeletal C protein, respectively. Furthermore, a murine model of experimental myositis was generated by immunization with a murine recombinant histidyl-tRNA synthetase, Jo-1, in which muscle and lung inflammation reflecting anti-synthetase syndrome are induced depending on acquired immunity. Recently, the transfer of human IgGs from patients with immune-mediated necrotizing myopathy, comprising anti-signal recognition particles and anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies, was found to induce complement-mediated myositis in recipient mice. CD8+ T cell-mediated myositis can be established depending on autoimmunity against transcriptional intermediary factor 1γ (TIF1γ), an autoantigen for MSAs induced by recombinant human TIF1γ immunization. These new murine models reflecting MSA-related IIMs are useful tools for accurately understanding the pathological mechanisms underlying IIMs.
first_indexed 2024-04-10T16:26:11Z
format Article
id doaj.art-c738d3754d2745b7bfc3fb67f12240d0
institution Directory Open Access Journal
issn 2578-5826
language English
last_indexed 2024-04-10T16:26:11Z
publishDate 2023-01-01
publisher Taylor & Francis Group
record_format Article
series Immunological Medicine
spelling doaj.art-c738d3754d2745b7bfc3fb67f12240d02023-02-09T05:34:36ZengTaylor & Francis GroupImmunological Medicine2578-58262023-01-0146191410.1080/25785826.2022.2137968Murine models of idiopathic inflammatory myopathyRisa Konishi0Yuki Ichimura1Naoko Okiyama2Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, JapanDepartment of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, JapanDepartment of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, JapanAbstractIdiopathic inflammatory myopathies (IIMs) are characterized by inflammation of muscles and other organs. Several myositis-specific autoantibodies (MSAs) have been identified in IIMs and were found to be associated with distinct clinical features. Although MSAs are valuable for the diagnosis of IIMs, the pathogenic roles of these antibodies remain unknown. To investigate the pathogenesis of IIMs, several animal models of experimental myositis have been established. Classical murine models of autoimmune myositis, experimental autoimmune myositis, and C protein-induced myositis are established by immunization with muscle-specific antigens, myosin, and skeletal C protein, respectively. Furthermore, a murine model of experimental myositis was generated by immunization with a murine recombinant histidyl-tRNA synthetase, Jo-1, in which muscle and lung inflammation reflecting anti-synthetase syndrome are induced depending on acquired immunity. Recently, the transfer of human IgGs from patients with immune-mediated necrotizing myopathy, comprising anti-signal recognition particles and anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies, was found to induce complement-mediated myositis in recipient mice. CD8+ T cell-mediated myositis can be established depending on autoimmunity against transcriptional intermediary factor 1γ (TIF1γ), an autoantigen for MSAs induced by recombinant human TIF1γ immunization. These new murine models reflecting MSA-related IIMs are useful tools for accurately understanding the pathological mechanisms underlying IIMs.https://www.tandfonline.com/doi/10.1080/25785826.2022.2137968Murine modelidiopathic inflammatory myopathydermatomyositismyositis-specific autoantibodyTIF1γ
spellingShingle Risa Konishi
Yuki Ichimura
Naoko Okiyama
Murine models of idiopathic inflammatory myopathy
Immunological Medicine
Murine model
idiopathic inflammatory myopathy
dermatomyositis
myositis-specific autoantibody
TIF1γ
title Murine models of idiopathic inflammatory myopathy
title_full Murine models of idiopathic inflammatory myopathy
title_fullStr Murine models of idiopathic inflammatory myopathy
title_full_unstemmed Murine models of idiopathic inflammatory myopathy
title_short Murine models of idiopathic inflammatory myopathy
title_sort murine models of idiopathic inflammatory myopathy
topic Murine model
idiopathic inflammatory myopathy
dermatomyositis
myositis-specific autoantibody
TIF1γ
url https://www.tandfonline.com/doi/10.1080/25785826.2022.2137968
work_keys_str_mv AT risakonishi murinemodelsofidiopathicinflammatorymyopathy
AT yukiichimura murinemodelsofidiopathicinflammatorymyopathy
AT naokookiyama murinemodelsofidiopathicinflammatorymyopathy